Proficio Capital Partners LLC Purchases Shares of 21,190 Ingevity Co. (NYSE:NGVT)

Proficio Capital Partners LLC purchased a new stake in Ingevity Co. (NYSE:NGVT) in the 4th quarter, according to its most recent filing with the SEC. The fund purchased 21,190 shares of the company’s stock, valued at approximately $863,000.

Other institutional investors also recently bought and sold shares of the company. First Horizon Advisors Inc. raised its holdings in Ingevity by 45.9% in the 3rd quarter. First Horizon Advisors Inc. now owns 862 shares of the company’s stock valued at $34,000 after acquiring an additional 271 shares during the last quarter. KBC Group NV raised its position in shares of Ingevity by 50.8% in the 3rd quarter. KBC Group NV now owns 1,574 shares of the company’s stock worth $61,000 after buying an additional 530 shares during the period. Empowered Funds LLC purchased a new position in shares of Ingevity in the 4th quarter worth $187,000. Hennion & Walsh Asset Management Inc. purchased a new position in shares of Ingevity in the 4th quarter worth $239,000. Finally, XTX Topco Ltd purchased a new position in shares of Ingevity in the 3rd quarter worth $260,000. 91.59% of the stock is currently owned by institutional investors and hedge funds.

Ingevity Trading Down 2.0 %

NYSE:NGVT opened at $42.26 on Friday. The business’s 50-day moving average is $45.28 and its two-hundred day moving average is $42.28. The company has a debt-to-equity ratio of 6.86, a current ratio of 1.87 and a quick ratio of 1.04. Ingevity Co. has a 12 month low of $30.90 and a 12 month high of $56.30. The firm has a market capitalization of $1.54 billion, a PE ratio of -3.57 and a beta of 1.53.

Ingevity (NYSE:NGVT) last released its quarterly earnings data on Tuesday, February 18th. The company reported $0.95 EPS for the quarter, beating the consensus estimate of $0.29 by $0.66. Ingevity had a positive return on equity of 41.44% and a negative net margin of 30.60%. The company had revenue of $298.80 million for the quarter, compared to analyst estimates of $297.40 million. Research analysts predict that Ingevity Co. will post 4.45 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on NGVT shares. StockNews.com raised Ingevity from a “hold” rating to a “buy” rating in a research report on Thursday, February 20th. BMO Capital Markets raised Ingevity from a “market perform” rating to an “outperform” rating and increased their target price for the stock from $62.00 to $65.00 in a research report on Wednesday, February 26th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $55.17.

Ingevity Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.